Profile

Jill joined the Division of Diabetes, Endocrinology and Metabolism in 2016, where she serves as a Projects Manager for various scientific projects within the Al Powers group.

She is a long standing Vanderbilt employee whose career spans clinical research, basic research, secondary education, website application support and project management.

Jill began her Vanderbilt career as a research assistant in the Rabin lab developing and performing radioimmunoassays for reproductive hormones, studying hormonal secretion in cell lines, fractionating human serum via column chromatography and assisting with clinical research performed in the Clinical Research Center, VUMC.

Jill then migrated to basic research in the Magnuson lab where she performed gene targeting in mouse embryonic stem cells (mESCs), DNA microinjection,  mESC injection into blastocysts, microsurgeries, and a variety of other techniques designed to study genes related to diabetes.

While working as a Senior Research Specialist in the Magnuson Lab, Jill completed her Masters of Education and took a one year hiatus to teach high school Biology and Ecology at John Overton High School, Nashville, TN.  

She subsequently returned to Vanderbilt and worked as an Application Support Analyst where she taught individuals how to utilize Labnodes, a web based application designed to help scientists manage their research.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Mind bomb 1 is required for pancreatic β-cell formation. Horn S, Kobberup S, Jørgensen MC, Kalisz M, Klein T, Kageyama R, Gegg M, Lickert H, Lindner J, Magnuson MA, Kong YY, Serup P, Ahnfelt-Rønne J, Jensen JN (2012) Proc Natl Acad Sci U S A 109(19): 7356-61
    › Primary publication · 22529374 (PubMed) · PMC3358874 (PubMed Central)
  2. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA (2011) Diabetes 60(3): 827-37
    › Primary publication · 21266327 (PubMed) · PMC3046843 (PubMed Central)
  3. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Artner I, Hang Y, Mazur M, Yamamoto T, Guo M, Lindner J, Magnuson MA, Stein R (2010) Diabetes 59(10): 2530-9
    › Primary publication · 20627934 (PubMed) · PMC3279542 (PubMed Central)
  4. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Burgess SC, He T, Yan Z, Lindner J, Sherry AD, Malloy CR, Browning JD, Magnuson MA (2007) Cell Metab 5(4): 313-20
    › Primary publication · 17403375 (PubMed) · PMC2680089 (PubMed Central)
  5. Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations. Pino MF, Kim KA, Shelton KD, Lindner J, Odili S, Li C, Collins HW, Shiota M, Matschinsky FM, Magnuson MA (2007) J Biol Chem 282(18): 13906-16
    › Primary publication · 17353190 (PubMed)
  6. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA (2006) Dev Cell 11(4): 583-9
    › Primary publication · 16962829 (PubMed)
  7. Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Schonhoff S, Baggio L, Ratineau C, Ray SK, Lindner J, Magnuson MA, Drucker DJ, Leiter AB (2005) Mol Cell Biol 25(10): 4189-99
    › Primary publication · 15870288 (PubMed) · PMC1087718 (PubMed Central)
  8. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA (2005) Proc Natl Acad Sci U S A 102(17): 6207-12
    › Primary publication · 15833818 (PubMed) · PMC556131 (PubMed Central)
  9. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. Burgess SC, Hausler N, Merritt M, Jeffrey FM, Storey C, Milde A, Koshy S, Lindner J, Magnuson MA, Malloy CR, Sherry AD (2004) J Biol Chem 279(47): 48941-9
    › Primary publication · 15347677 (PubMed)
  10. Efficient DNA cassette exchange in mouse embryonic stem cells by staggered positive-negative selection. Long Q, Shelton KD, Lindner J, Jones JR, Magnuson MA (2004) Genesis 39(4): 256-62
    › Primary publication · 15286998 (PubMed)
  11. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA (2002) J Biol Chem 277(40): 37176-83
    › Primary publication · 12149271 (PubMed)
  12. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA (1999) J Biol Chem 274(1): 305-15
    › Primary publication · 9867845 (PubMed)
  13. Targeted oncogenesis of hormone-negative pancreatic islet progenitor cells. Jetton TL, Moates JM, Lindner J, Wright CV, Magnuson MA (1998) Proc Natl Acad Sci U S A 95(15): 8654-9
    › Primary publication · 9671733 (PubMed) · PMC21131 (PubMed Central)
  14. Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5' regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals. Wang R, Macmillan LB, Fremeau RT, Magnuson MA, Lindner J, Limbird LE (1996) Neuroscience 74(1): 199-218
    › Primary publication · 8843087 (PubMed)
  15. Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. Lindner J, McNeil LW, Marney S, Conway M, Rivier J, Vale W, Rabin D (1981) J Clin Endocrinol Metab 52(2): 267-70
    › Primary publication · 7007403 (PubMed)
  16. Dissociation of LH and FSH Responses to LHRH during estrogen therapy of patients with ovarian failure. Linde R, Lindner J, Lorber D, Rabin D (1982) Horm Metab Res 14(3): 154-6
    › Primary publication · 6802737 (PubMed)
  17. A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man. Evans RM, Doelle GC, Lindner J, Bradley V, Rabin D (1984) J Clin Invest 73(1): 262-6
    › Primary publication · 6228566 (PubMed) · PMC425009 (PubMed Central)
  18. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration. Pavlou SN, Dahl KD, Wakefield G, Rivier J, Vale W, Hsueh AJ, Lindner J (1988) J Clin Endocrinol Metab 66(5): 1005-9
    › Primary publication · 2834409 (PubMed)
  19. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M (1989) J Clin Endocrinol Metab 68(2): 446-54
    › Primary publication · 2537334 (PubMed)
  20. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ (1990) J Clin Endocrinol Metab 70(5): 1472-8
    › Primary publication · 2110578 (PubMed)
  21. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM (1991) J Clin Endocrinol Metab 73(6): 1360-9
    › Primary publication · 1955518 (PubMed)
  22. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. Lindner J, Rivier JE, Vale WW, Pavlou SN (1990) J Clin Endocrinol Metab 70(4): 1219-24
    › Primary publication · 1690747 (PubMed)
  23. Isolated follicle-stimulating hormone deficiency revisited. Ovulation and conception in presence of circulating antibody to follicle-stimulating hormone. Rabinowitz D, Benveniste R, Linder J, Lorber D, Daniell J (1979) N Engl J Med 300(3): 126-8
    › Primary publication · 758600 (PubMed)
  24. Human chorionic gonadotropin alpha-subunit from cultured choriocarcinoma (JEG) cells: comparison of the subunit secreted free with that prepared from secreted human chorionic gonadotropin. Benveniste R, Lindner J, Puett D, Rabin D (1979) Endocrinology 105(3): 581-7
    › Primary publication · 572760 (PubMed)
  25. Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells. Benveniste R, Speeg KV, Carpenter G, Cohen S, Lindner J, Rabinowitz D (1978) J Clin Endocrinol Metab 46(1): 169-72
    › Primary publication · 312807 (PubMed)